Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 172

1.

Biomimetic cardiovascular platforms for in vitro disease modeling and therapeutic validation.

Portillo-Lara R, Spencer AR, Walker BW, Shirzaei Sani E, Annabi N.

Biomaterials. 2018 Aug 4. pii: S0142-9612(18)30564-7. doi: 10.1016/j.biomaterials.2018.08.010. [Epub ahead of print]

PMID:
30201502
2.

Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5).

Chen T, Reich NW, Bell N, Finn PD, Rodriguez D, Kohler J, Kozuka K, He L, Spencer AG, Charmot D, Navre M, Carreras CW, Koo-McCoy S, Tabora J, Caldwell JS, Jacobs JW, Lewis JG.

J Med Chem. 2018 Sep 13;61(17):7589-7613. doi: 10.1021/acs.jmedchem.8b00308. Epub 2018 Aug 24.

PMID:
30141927
3.

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis.

Gay F, Jackson G, Rosiñol L, Holstein SA, Moreau P, Spada S, Davies F, Lahuerta JJ, Leleu X, Bringhen S, Evangelista A, Hulin C, Panzani U, Cairns DA, Di Raimondo F, Macro M, Liberati AM, Pawlyn C, Offidani M, Spencer A, Hájek R, Terpos E, Morgan GJ, Bladé J, Sonneveld P, San-Miguel J, McCarthy PL, Ludwig H, Boccadoro M, Mateos MV, Attal M.

JAMA Oncol. 2018 Aug 9. doi: 10.1001/jamaoncol.2018.2961. [Epub ahead of print]

PMID:
30098165
4.

Mining the Plasma Cell Transcriptome for Novel Cell Surface Proteins.

Trezise S, Karnowski A, Fedele PL, Mithraprabhu S, Liao Y, D'Costa K, Kueh AJ, Hardy MP, Owczarek CM, Herold MJ, Spencer A, Shi W, Willis SN, Nutt SL, Corcoran LM.

Int J Mol Sci. 2018 Jul 24;19(8). pii: E2161. doi: 10.3390/ijms19082161.

5.

Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma.

Mithraprabhu S, Sirdesai S, Chen M, Khong T, Spencer A.

Int J Mol Sci. 2018 Jun 24;19(7). pii: E1858. doi: 10.3390/ijms19071858.

6.

Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response.

Mina R, Petrucci MT, Corradini P, Spada S, Patriarca F, Cerrato C, De Paoli L, Pescosta N, Ria R, Malfitano A, Musto P, Baldini L, Guglielmelli T, Gamberi B, Mannina D, Benevolo G, Zambello R, Falcone AP, Palumbo A, Nagler A, Calafiore V, Hájek R, Spencer A, Boccadoro M, Bringhen S.

Clin Lymphoma Myeloma Leuk. 2018 Aug;18(8):533-540. doi: 10.1016/j.clml.2018.05.019. Epub 2018 May 28.

PMID:
29910180
7.

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

Gopal AK, Schuster SJ, Fowler NH, Trotman J, Hess G, Hou JZ, Yacoub A, Lill M, Martin P, Vitolo U, Spencer A, Radford J, Jurczak W, Morton J, Caballero D, Deshpande S, Gartenberg GJ, Wang SS, Damle RN, Schaffer M, Balasubramanian S, Vermeulen J, Cheson BD, Salles G.

J Clin Oncol. 2018 Aug 10;36(23):2405-2412. doi: 10.1200/JCO.2017.76.8853. Epub 2018 May 31.

PMID:
29851546
8.

Analysis of Circulating Tumor DNA.

Mithraprabhu S, Spencer A.

Methods Mol Biol. 2018;1792:129-145. doi: 10.1007/978-1-4939-7865-6_9.

PMID:
29797256
9.

DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma.

Yuen HLA, Low MSY, Fedele P, Kalff A, Walker P, Bergin K, Coutsouvelis J, Grigoriadis G, Spencer A.

Leuk Lymphoma. 2018 Apr 4:1-5. doi: 10.1080/10428194.2018.1454595. [Epub ahead of print]

PMID:
29616871
10.

Critical review of the validity of patient satisfaction questionnaires pertaining to oral health care.

Nair R, Ishaque S, Spencer AJ, Luzzi L, Do LG.

Community Dent Oral Epidemiol. 2018 Aug;46(4):369-375. doi: 10.1111/cdoe.12377. Epub 2018 Mar 30.

PMID:
29603328
11.

Dental knowledge and dental service utilization: A 2-year follow-up study.

Amarasena N, Spencer AJ, Roberts-Thomson KF, Brennan DS.

Community Dent Oral Epidemiol. 2018 Aug;46(4):336-342. doi: 10.1111/cdoe.12371. Epub 2018 Feb 20.

PMID:
29461636
12.

Extending Circulating Tumor DNA Analysis to Ultralow Abundance Mutations: Techniques and Challenges.

Rodda AE, Parker BJ, Spencer A, Corrie SR.

ACS Sens. 2018 Mar 23;3(3):540-560. doi: 10.1021/acssensors.7b00953. Epub 2018 Feb 23.

PMID:
29441780
13.

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.

Quach H, Benson S, Haysom H, Wilkes AM, Zacher N, Cole-Sinclair M, Miles Prince H, Mollee P, Spencer A, Joy Ho P, Harrison SJ, Lee C, Augustson B, Daly J.

Intern Med J. 2018 Feb;48(2):210-220. doi: 10.1111/imj.13707.

PMID:
29415351
14.

Circulating tumour DNA analysis in multiple myeloma.

Mithraprabhu S, Spencer A.

Oncotarget. 2017 Oct 7;8(53):90610-90611. doi: 10.18632/oncotarget.21595. eCollection 2017 Oct 31. No abstract available.

15.

Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

Yong MK, Cameron PU, Slavin MA, Cheng AC, Morrissey CO, Bergin K, Spencer A, Ritchie D, Lewin SR.

Front Immunol. 2017 Nov 9;8:1506. doi: 10.3389/fimmu.2017.01506. eCollection 2017.

16.

Transplant results in adults with Fanconi anaemia.

Bierings M, Bonfim C, Peffault De Latour R, Aljurf M, Mehta PA, Knol C, Boulad F, Tbakhi A, Esquirol A, McQuaker G, Sucak GA, Othman TB, Halkes CJM, Carpenter B, Niederwieser D, Zecca M, Kröger N, Michallet M, Risitano AM, Ehninger G, Porcher R, Dufour C; EBMT SAA WP.

Br J Haematol. 2018 Jan;180(1):100-109. doi: 10.1111/bjh.15006. Epub 2017 Nov 2.

PMID:
29094350
17.

A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results.

Spencer A, Harrison S, Zonder J, Badros A, Laubach J, Bergin K, Khot A, Zimmerman T, Chauhan D, Levin N, MacLaren A, Reich SD, Trikha M, Richardson P.

Br J Haematol. 2018 Jan;180(1):41-51. doi: 10.1111/bjh.14987. Epub 2017 Oct 26.

PMID:
29076150
18.

Factors Influencing Early Feeding of Foods and Drinks Containing Free Sugars-A Birth Cohort Study.

Ha DH, Do LG, Spencer AJ, Thomson WM, Golley RK, Rugg-Gunn AJ, Levy SM, Scott JA.

Int J Environ Res Public Health. 2017 Oct 23;14(10). pii: E1270. doi: 10.3390/ijerph14101270.

19.

Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials.

Schlenk RF, Krauter J, Raffoux E, Kreuzer KA, Schaich M, Noens L, Pabst T, Vusirikala M, Bouscary D, Spencer A, Candoni A, Gil JS, Berkowitz N, Weber HJ, Ottmann O.

Haematologica. 2018 Jan;103(1):e25-e28. doi: 10.3324/haematol.2017.172411. Epub 2017 Oct 19. No abstract available.

20.

Defibrotide for the treatment of sinusoidal obstruction syndrome: evaluation of response to therapy and patient outcomes.

Coutsouvelis J, Avery S, Dooley M, Kirkpatrick C, Spencer A.

Support Care Cancer. 2018 Mar;26(3):947-955. doi: 10.1007/s00520-017-3915-1. Epub 2017 Oct 11.

PMID:
29022099

Supplemental Content

Loading ...
Support Center